MRRS adds "Neuroendocrine Tumors – Pipeline Review, H2 2016" latest studies, published in December 2016. It is a professional and in-depth study.

Summary
Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Pipeline Review, H2 2016, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

Neuroendocrine tumor begins in the hormone-producing cells of the body’s neuroendocrine system, which is made up of cells that are a cross between traditional endocrine cells (or hormone-producing cells) and nerve cells. Symptom includes hyperglycemia, diarrhea, loss of appetite/weight loss, thickening or lump in any part of the body, jaundice, headache, anxiety and gastric ulcer disease. Treatments include surgery, radiation therapy and chemotherapy.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Neuroendocrine Tumors (Oncology).
– The pipeline guide reviews pipeline therapeutics for Neuroendocrine Tumors (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Neuroendocrine Tumors (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Neuroendocrine Tumors (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Neuroendocrine Tumors (Oncology)

Table Of Contents
Table of Contents 2
Introduction 5
Neuroendocrine Tumors Overview 6
Therapeutics Development 7
Neuroendocrine Tumors - Therapeutics under Development by Companies 9
Neuroendocrine Tumors - Therapeutics under Investigation by Universities/Institutes 12
Neuroendocrine Tumors - Pipeline Products Glance 13
Neuroendocrine Tumors - Products under Development by Companies 16
Neuroendocrine Tumors - Products under Investigation by Universities/Institutes 20
Neuroendocrine Tumors - Companies Involved in Therapeutics Development 21
Neuroendocrine Tumors - Therapeutics Assessment 62
Drug Profiles 75
Neuroendocrine Tumors - Dormant Projects 335
Neuroendocrine Tumors - Discontinued Products 337
Neuroendocrine Tumors - Product Development Milestones 338
Appendix 349
....

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/neuroendocrine-tumors-pipeline-review-h2-2016

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.